Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites

被引：0
作者：
Sebastian Maurer-Stroh
Jianmin Ma
Raphael Tze Chuen Lee
Fernanda L Sirota
Frank Eisenhaber
机构：
[1] Agency for Science Technology and Research (A*STAR),Biomolecular Function Discovery Division, Bioinformatics Institute (BII)
[2] National University of Singapore,Department of Biological Sciences
来源：
Biology Direct | / 4卷
关键词：
Oseltamivir; Zanamivir; Neuraminidase Inhibitor; H1N1 Strain; Antibody Binding Site;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection
    E. Cordero
    T. Aydillo
    M. C. Fariñas
    J. R. Paño-Pardo
    J. Pachón
    D. Viasus
    M. Riera
    F. López-Medrano
    A. Payeras
    A. Moreno
    J. Rodríguez-Baño
    J. A. Oteo
    J. Martínez-Montauti
    J. Torre-Cisneros
    F. Segura
    J. Carratalá
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 547 - 556
  • [32] Modeling gene sequences over time in 2009 H1N1 Influenza A Virus populations
    Natalia Goñi
    Alvaro Fajardo
    Gonzalo Moratorio
    Rodney Colina
    Juan Cristina
    Virology Journal, 6
  • [33] Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses
    Nazanin Zahra Shafiei Jandaghi
    Talat Mokhtari Azad
    Maryam Naseri
    Jila Yavarian
    Rakhshandeh Nategh
    Archives of Virology, 2010, 155 : 717 - 721
  • [34] Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses
    Jandaghi, Nazanin Zahra Shafiei
    Azad, Talat Mokhtari
    Naseri, Maryam
    Yavarian, Jila
    Nategh, Rakhshandeh
    ARCHIVES OF VIROLOGY, 2010, 155 (05) : 717 - 721
  • [35] The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009-2010 Influenza A Virus Subtype H1N1 Pandemic
    Aoki, Fred Y.
    Hayden, Frederick G.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (04) : 547 - 549
  • [36] Influenza A (H1N1) 2009. Review
    Mahassin, F.
    Jaureguiberry, S.
    Monsel, G.
    Caumes, E.
    Bricaire, F.
    ANTIBIOTIQUES, 2010, 12 (04): : 235 - 242
  • [37] Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009)
    Miyachi, Kiyomitsu
    Watanabe, Atushi
    Iida, Hiromasa
    Hattori, Haruki
    Ukai, Hiroshi
    Takano, Tsuruyo
    Hankins, Raleigh W.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (04) : 524 - 529
  • [38] Supply of Neuraminidase Inhibitors Related to Reduced Influenza A (H1N1) Mortality during the 2009-2010 H1N1 Pandemic: An Ecological Study
    Miller, Paula E.
    Rambachan, Aksharananda
    Hubbard, Roderick J.
    Li, Jiabai
    Meyer, Alison E.
    Stephens, Peter
    Mounts, Anthony W.
    Rolfes, Melissa A.
    Penn, Charles R.
    PLOS ONE, 2012, 7 (09):
  • [39] Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation
    Kawai, Naoki
    Ikematsu, Hideyuki
    Iwaki, Norio
    Kondou, Kunio
    Hirotsu, Nobuo
    Kawashima, Takashi
    Maeda, Tetsunari
    Tanaka, Osame
    Doniwa, Ken-ichi
    Kashiwagi, Seizaburo
    JOURNAL OF INFECTION, 2009, 59 (03) : 207 - 212
  • [40] Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India
    Babasaheb V Tandale
    Shailesh D Pawar
    Yogesh K Gurav
    Mandeep S Chadha
    Santosh S Koratkar
    Vijay N Shelke
    Akhilesh C Mishra
    BMC Infectious Diseases, 10
12345